Dian Diagnostics

Forecast & Rating8 analysts currently cover Dian Diagnostics, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥19.24, about 14.6% upside from the current price of ¥16.79. Price targets range from ¥14.00 to ¥24.46 — a wide spread, showing clear disagreement over just how much Dian Diagnostics can rise. Historically, about 14.4% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Dian Diagnostics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 24, 2026; for reference only and not investment advice.